| Catalog No. |
Size |
Price |
Figures |
|---|
Z02014-1 mg
| 1 mg | $ 630.00 |
References:
- Dadaglio G, et al. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes. J. Immunol. Oct 1991; 147(7): 2302-2309.
- Tani Y, et al. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins. J. Immunol. Dec 1993; 151(12): 7337-7348.
|
|---|
| Full Name | | Human Immunodeficiency Virus (HIV)-1, 2 Envelope |
|
| Abbreviated Name-1 | HIV-I,II envelope |
|---|
| Description | E. coli derived recombinant. Human Immunodeficiency Virus (HIV)-1, 2 Envelope contains the C-terminus of gp120 and most of gp41. The protein is conjugated to a 23 amino acids synthetic peptide derived from gp36 of HIV-II. |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >95% pure (As determined by HPLC-C4, and 10% PAGE). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, Store at -20°C. |
|---|
| Concentration | 1 mg/ml in 100 mM Na-PO4, pH 6, 0.05% SDS |
|---|
| Stability | Five years frozen. One month in solution at 4°C. |
|---|
| Specificity | Immunoreactive with all sera of HIV-I, HIV type-O & HIV-II infected individuals. |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for early detection of HIV seroconvertors with minimal specificity problems. |
|---|
